Platelet-activating factor as a mediator of allergic disease.
about
Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.Herbal interventions in asthma and allergy.Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease.Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects.Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responsesPlatelet activating factor and asthma.Eicosanoids and platelet-activating factor in allergic respiratory diseases.The use of corticosteroids in childhood asthma.Platelet activating factor: A potential biomarker in acute coronary syndrome?Comprehensive asthma management: guidelines for clinicians.Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response.New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future.PAF and asthma--time for an appraisal?Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.The role of platelet activating factor in airway inflammation, airway hyperresponsiveness, and pulmonary function in monkeys.Phospholipase A2-induced pathophysiologic changes in the guinea pig lung.Characterization of platelet-activating factor-induced elevation of cytosolic free calcium concentration in eosinophils.Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor.A PAF receptor antagonist inhibits acute airway inflammation and late-phase responses but not chronic airway inflammation and hyperresponsiveness in a primate model of asthma.The actions of GR32191B, a thromboxane receptor antagonist, on the effects of inhaled PAF on human airways.Experimental otitis media with effusion induced by platelet activating factor.Cold urticaria as a model of mediator release: platelet factor 4, eosinophil cationic protein and histamine.Lipid mediators contribute to oxygen-radical-induced airway responses in sheep.Effect of BN 52021, a platelet activating factor antagonist, on dithranol-induced inflammation.Direct effects and augmentation of airway smooth muscle contraction caused by phospholipase A2.PAF mediates cigarette smoke-induced goblet cell metaplasia in guinea pig airways.Effect of WEB 2170 BS, platelet activating factor receptor inhibitor, in the guinea pig model of middle ear inflammation.Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways.Effects of platelet activating factor on vascular permeability of the middle ear mucosa.Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9.Phospholipid signaling in innate immune cells.The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro.Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.
P2860
Q30498702-746C058B-3BDC-4344-9426-77DD0501A558Q33541182-394BA991-3CF5-4703-9FF1-34671B63E700Q33855065-F5DB573F-1979-46D6-AB53-9239332E753EQ34417767-919DB7FB-BF35-4688-A8AC-20A3B0A52D30Q36196472-6138BCF0-1892-470B-AF90-E4845A89F382Q36269382-BDD27ADC-5BDD-4252-8BD6-4725FC0B8876Q36281989-263453D1-BA02-4E79-AD3A-4F9859451959Q36440019-A3BDFBD3-07F3-4E31-B4BA-03FBDE3D3673Q37330071-8FD251D3-5887-4CEF-B00E-533971F21C67Q38791972-2E5A93E3-D8AF-43BD-A538-0F956ECCE8BDQ38993442-D3DC39A0-AAF3-4176-9DC0-C51F09E14F91Q39442838-FDB48AC0-D088-4475-9F3B-6F3D394201B4Q40897920-7ECBE8A4-492B-4CA8-A9A9-32C50F27858AQ40907591-D1ABD852-2FEE-4078-BFD8-328FECE30202Q41121327-5BF272D4-CF82-475F-92AA-BFF7B0B67A73Q41142725-F6C3B6D0-A712-47B6-B062-3FA5E8CAD49EQ41776479-EE3893B0-188F-4C05-BBCB-1BD412E1157AQ42484938-254A09D7-BCA3-4161-84E6-C186F904C337Q42505317-F8637FCA-0ACC-4A44-AFEB-DA476E86EB32Q42943607-DA122A60-E132-49A9-8102-EBDBD4EED8E7Q43203853-756822BD-ACA0-4F8F-9887-A3C4EF14C238Q44171266-FF067194-FD2B-4F67-A895-75E634076BCDQ44534545-CE7DCE98-D66F-44A3-A8E5-0BB449CAF7FEQ44568851-F7D271CD-0403-47CB-89B7-8B48710039ECQ45044329-2EE29B48-4611-4933-89E3-3FA3A3F5F99DQ45271615-155AB502-4F42-4BA4-97A6-E9A9B5B35EE0Q46372186-78E70D4F-8D29-4C5A-9511-C9C59D464D18Q46578531-4A97A92C-0502-4052-84B6-EC2A51474C12Q46682830-7FA9786E-1465-49C6-B770-EDD50CEAA9A0Q50506781-A900254C-1FFE-488F-8278-47E2B2F6537BQ50527848-D302088C-4E8D-47AD-B17D-EEE1F6F0F816Q50803254-FE854270-2B25-42DF-A3B9-F93ACD2DFC1DQ51699859-F6374B88-EAC8-478D-A122-B82ACFECF3B5Q52312849-BA6FB552-A37B-4A8D-875B-FE760C1A9BF3Q52484681-B0FE4A6F-4D1F-4BAB-BE3B-B7D24DED36A6Q54327140-78D5F432-8AB9-414A-AA46-4394D78B1CBF
P2860
Platelet-activating factor as a mediator of allergic disease.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Platelet-activating factor as a mediator of allergic disease.
@en
Platelet-activating factor as a mediator of allergic disease.
@nl
type
label
Platelet-activating factor as a mediator of allergic disease.
@en
Platelet-activating factor as a mediator of allergic disease.
@nl
prefLabel
Platelet-activating factor as a mediator of allergic disease.
@en
Platelet-activating factor as a mediator of allergic disease.
@nl
P2093
P1476
Platelet-activating factor as a mediator of allergic disease.
@en
P2093
P304
P356
10.1016/0091-6749(88)90952-9
P407
P433
P577
1988-05-01T00:00:00Z